https://charts.traderzeitung.de/phases/US74019P2074 string(1403) "{"isin":"US74019P2074","name":"Precision BioSciences Inc","stock_id_xnas":65845099,"stock_id_xnys":null,"generated_at":"2026-09-24 01:33:00","days":[{"date":"2026-09-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":6.51,"close_at":"2026-09-21 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-22","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":7.17,"close_at":"2026-09-22 21:59:00","complete":true,"perf_pct":10.1382},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":6.36,"close_at":"2026-09-23 21:59:00","complete":true,"perf_pct":-11.2971},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":false,"perf_pct":null}]}]}"

Precision BioSciences Aktie News & Nachrichten

[WKN: A400AS | Symbol: DTIL]

Realtimekurs

Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. It operates through the Therapeutics and Food segments. The Therapeutics segment focuses on the development of products in the field of immuno-oncology and of novel products outside immuno-oncology to treat human diseases. The Food segment applies ARCUS, the company's proprietary genome editing platform, to develop food and nutrition products through collaboration agreements with consumer-facing companies. The company was founded by Derek N. Jantz, Jeff Smith, and Matthew R. Kane on January 26, 2006 and is headquartered in Durham, NC.

10J

Alles

Vorbörsliche Indikationen

Regulärer Handel

Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über Precision BioSciences gefunden werden.

Precision BioSciences Nachrichtenticker öffnen

MT Newswires 24.08.2026 12:47 Uhr

Precision BioSciences verabreicht ersten Patienten Dosis in Studie zu potenzieller Behandlung der Duchenne-Muskeldystrophie

06:46 AM EDT, 24.08.2026 (MT Newswires) -- Precision BioSciences (DTIL) hat in diesem Monat mit der Verabreichung der Dosis an den ersten Patienten in

MT Newswires 29.06.2026 20:45 Uhr

Precision BioSciences tritt dem Russell 2000 Index bei

02:44 PM EDT, 06/29/2026 (MT Newswires) -- Precision BioSciences (DTIL) sagte am Montag, dass es nach Börsenschluss der US-Aktienmärkte am Freitag in

MT Newswires 09.06.2026 13:11 Uhr

Oppenheimer stuft Precision BioSciences mit Outperform ein

07:10 AM EDT, 06/09/2026 (MT Newswires) -- Precision BioSciences (DTIL) wird laut von FactSet befragten Analysten durchschnittlich mit Kaufen bewertet